2012
DOI: 10.1089/gen.32.3.13
|View full text |Cite
|
Sign up to set email alerts
|

Measuring and Characterizing Protein Aggregates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2013
2013
2013
2013

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…These complex macromolecules have colloidal behaviors that can considerably affect their therapeutic value, delivery systems, shelf life, and most importantly, patient safety. 1,4 As a result, both the pharmaceutical industry and the regulatory agencies have taken a keen interest in analytical methods that can reliably characterize the properties of these macromolecules, their aggregates, and their associated drug-delivery systems. 1,4 It should be noted that the term aggregates in the pharmaceutical industry refers to any self-associated nonnative species from dimers to visible particles 4 and therefore implies a very large range of sizes and types.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…These complex macromolecules have colloidal behaviors that can considerably affect their therapeutic value, delivery systems, shelf life, and most importantly, patient safety. 1,4 As a result, both the pharmaceutical industry and the regulatory agencies have taken a keen interest in analytical methods that can reliably characterize the properties of these macromolecules, their aggregates, and their associated drug-delivery systems. 1,4 It should be noted that the term aggregates in the pharmaceutical industry refers to any self-associated nonnative species from dimers to visible particles 4 and therefore implies a very large range of sizes and types.…”
Section: Introductionmentioning
confidence: 99%
“…1,4 As a result, both the pharmaceutical industry and the regulatory agencies have taken a keen interest in analytical methods that can reliably characterize the properties of these macromolecules, their aggregates, and their associated drug-delivery systems. 1,4 It should be noted that the term aggregates in the pharmaceutical industry refers to any self-associated nonnative species from dimers to visible particles 4 and therefore implies a very large range of sizes and types. 1,2 The analytical chemistry and particle characterization industries have responded with improvements in standard characterization techniques such as multiangle and dynamic (DLS) light scattering, electrophoretic mobility, and particle counters and with improvements in the performance of fractionation-based methods such as size exclusion chromatography, field flow fractionation, and automatic ultracentrifugation.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…11 Further, sample fractionation when using size-exclusion chromatography, field-flow fractionation, or automatic ultracentrifugation is usually necessary to prepare a sample, but these fractionation methods are invasive to a sample and can alter its native state. 12,13 Overall, the need to combine several methods based on different measurement principles, different sensitivities, and different sample preparation requirements complicates data reconciliation.…”
Section: Introductionmentioning
confidence: 99%